SANA
Sana Biotechnology, Inc.Marquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Renaissance Technologies re-entered | Q3 2024(8Q snapshot) | 7Q | $4.91 | $3.04 | -38% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $4.75 | $3.04 | -36% |
| Two Sigma Investments | Q3 2024(8Q snapshot) | 7Q | $4.75 | $3.04 | -36% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $4.75 | $3.04 | -36% |
| D.E. Shaw re-entered | Q4 2024(8Q snapshot) | 6Q | $2.59 | $3.04 | +17% |
| AQR Capital Management | Q4 2024(8Q snapshot) | 6Q | $2.59 | $3.04 | +17% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Point72 Asset Management | Q1 2025 | Q2 2025 | → $1.71 | -46% |
| Duquesne Family Office | Q2 2024 | Q3 2024 | — | +0% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Sana Biotechnology, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 5, 2026 — the most recent Form 4 on file — not from today.
- Form 40001309988-26-000002Jun 5, 2026
- Form 40001645041-26-000002Jun 5, 2026
- Form 40001836301-26-000014Jun 5, 2026
- Form 40001757533-26-000011Jun 5, 2026
- Form 40001376247-26-000002Jun 5, 2026
- Form 40001480212-26-000006Jun 5, 2026
- Form 40001612312-26-000002Jun 5, 2026
- Form 40001770121-26-000003Jun 5, 2026
- Form 40001480212-26-000004Apr 8, 2026
- Form 40001627387-26-000004Mar 10, 2026
- Form 40001568605-26-000008Mar 10, 2026
- Form 40001568605-26-000006Mar 6, 2026
- Form 40001627387-26-000002Mar 6, 2026
- Form 40001568605-26-000004Mar 4, 2026
- Form 40001665924-26-000008Feb 18, 2026
Fundamentals
XBRL · Sana Biotechnology, Inc.Annual figures sourced directly from Sana Biotechnology, Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Sana Biotechnology, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventJun 5, 2026
- 8-KMaterial eventMay 15, 2026
- 10-QQuarterly reportMay 11, 2026
- 8-KMaterial eventMay 11, 2026
- DEF 14AProxy statementApr 24, 2026
- 8-KMaterial eventApr 24, 2026
- 8-KMaterial eventApr 13, 2026
- 10-KAnnual reportMar 3, 2026
- 8-KMaterial eventMar 3, 2026
- 8-KMaterial eventFeb 17, 2026
- 8-KMaterial eventJan 14, 2026
- 10-QQuarterly reportNov 6, 2025
- 8-KMaterial eventNov 6, 2025
- 8-KMaterial eventSep 5, 2025
- 8-KMaterial eventAug 29, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| D.E. Shaw | Q1 2026 | open | $3.85 | $3.04 | -21% |
| Renaissance Technologies | Q3 2025 | open | $3.33 | $3.04 | -9% |
| D.E. Shaw | Q2 2025 | Q4 2025 | $1.71 | $3.99 | +133% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | $3.16 | $1.71 | -46% |
| D.E. Shaw | Q4 2024 | Q1 2025 | $2.59 | $3.16 | +22% |
| AQR Capital Management | Q4 2024 | open | $2.59 | $3.04 | +17% |
| Citadel Advisors | Q3 2024 | open | $4.75 | $3.04 | -36% |
| Two Sigma Investments | Q3 2024 | open | $4.75 | $3.04 | -36% |
| Millennium Management | Q3 2024 | open | $4.75 | $3.04 | -36% |
| Renaissance Technologies | Q3 2024 | Q2 2025 | $4.91 | $1.78 | -64% |
| Duquesne Family Office | Q2 2024 | Q3 2024 | $0.00 | — | +0% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.